Cargando…

A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models

Many cancer cells rely on aerobic glycolysis for energy production and targeting of this pathway is a potential strategy to inhibit cancer cell growth. In this study, inhibition of five glycolysis pathway molecules (GLUT1, HKII, PFKFB3, PDHK1 and LDH) using 9 inhibitors (Phloretin, Quercetin, STF31,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xintaropoulou, Chrysi, Ward, Carol, Wise, Alan, Marston, Hugh, Turnbull, Arran, Langdon, Simon P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694858/ https://www.ncbi.nlm.nih.gov/pubmed/26259240

Ejemplares similares

Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment
por: Xintaropoulou, Chrysi, et al.
Publicado: (2018)

HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer
por: Jarman, Edward J., et al.
Publicado: (2019)

Predictive markers of endocrine response in breast cancer
por: Mosly, Duniya, et al.
Publicado: (2018)

Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells
por: Meehan, James, et al.
Publicado: (2017)

Development and characterisation of acquired radioresistant breast cancer cell lines
por: Gray, Mark, et al.
Publicado: (2019)

Inhibitors of the Fanconi anaemia pathway as potential antitumour agents for ovarian cancer
por: Taylor, Sarah J, et al.
Publicado: (2020)

Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers
por: Briffa, Romina, et al.
Publicado: (2015)

Noncoding RNAs in the Glycolysis of Ovarian Cancer
por: Zhang, Chunmei, et al.
Publicado: (2022)

Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer models
por: Martínez-Pérez, Carlos, et al.
Publicado: (2016)

Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer
por: Bonello, Maria, et al.
Publicado: (2018)

Diagnostics of Ovarian Tumors in Postmenopausal Patients
por: Mustafin, Chingis, et al.
Publicado: (2022)

Comparative Analysis of the Development of Acquired Radioresistance in Canine and Human Mammary Cancer Cell Lines
por: Gray, Mark, et al.
Publicado: (2020)

Corrigendum: Comparative Analysis of the Development of Acquired Radioresistance in Canine and Human Mammary Cancer Cell Lines
por: Gray, Mark, et al.
Publicado: (2021)

MICU1 drives glycolysis and chemoresistance in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2017)

Monitoring and modelling the dynamics of the cellular glycolysis pathway: A review and future perspectives
por: Patil, Nitin, et al.
Publicado: (2022)

The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing
por: Tesori, Valentina, et al.
Publicado: (2015)

LncRNA LINC00857 regulates the progression and glycolysis in ovarian cancer by modulating the Hippo signaling pathway
por: Lin, Xueke, et al.
Publicado: (2020)

The role of S-nitrosylation of PFKM in regulation of glycolysis in ovarian cancer cells
por: Gao, Wenwen, et al.
Publicado: (2021)

Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors
por: Codenotti, Silvia, et al.
Publicado: (2022)

Specific Pyruvate Kinase M2 Inhibitor, Compound 3K, Induces Autophagic Cell Death through Disruption of the Glycolysis Pathway in Ovarian Cancer Cells
por: Park, Jae Hyeon, et al.
Publicado: (2021)

Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models
por: Wise, Hannah C., et al.
Publicado: (2019)

Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors
por: Alvero, Ayesha B., et al.
Publicado: (2014)

Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomas
por: Gubbay, O, et al.
Publicado: (2005)

Activated heme synthesis regulates glycolysis and oxidative metabolism in breast and ovarian cancer cells
por: Kaur, Pritpal, et al.
Publicado: (2021)

Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients
por: Zheng, Jianfeng, et al.
Publicado: (2021)

Unbounded solutions of models for glycolysis
por: Brechmann, Pia, et al.
Publicado: (2021)

Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines
por: Attia, Yasmin M., et al.
Publicado: (2015)

The Wnt Signaling Pathway Inhibitors Improve the Therapeutic Activity of Glycolysis Modulators against Tongue Cancer Cells
por: Kleszcz, Robert, et al.
Publicado: (2022)

Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer
por: Meehan, James, et al.
Publicado: (2020)

Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 (‘Iressa’)
por: Sewell, J M, et al.
Publicado: (2002)

Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer
por: Sun, Li, et al.
Publicado: (2017)

Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines
por: Wilson, K E, et al.
Publicado: (1999)

2-Deoxyglucose, an Inhibitor of Glycolysis, Enhances the Oncolytic Effect of Coxsackievirus
por: Vorobyev, Pavel O., et al.
Publicado: (2022)

Nuclear factor erythroid 2-related factor 2 modulates HER4 receptor in ovarian cancer cells to influence their sensitivity to tyrosine kinase inhibitors
por: Kankia, Ibrahim H., et al.
Publicado: (2021)

NRF2 Regulates HER1 Signaling Pathway to Modulate the Sensitivity of Ovarian Cancer Cells to Lapatinib and Erlotinib
por: Kankia, Ibrahim H., et al.
Publicado: (2017)

Fast acting allosteric phosphofructokinase inhibitors block trypanosome glycolysis and cure acute African trypanosomiasis in mice
por: McNae, Iain W., et al.
Publicado: (2021)

Identification of a glycolysis‐related gene signature for survival prediction of ovarian cancer patients
por: Zhang, Dai, et al.
Publicado: (2021)

Peripheral Glycolysis in Neurodegenerative Diseases
por: Bell, Simon M., et al.
Publicado: (2020)

Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer
por: Langdon, Simon P., et al.
Publicado: (2020)

Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines.
por: Langdon, S. P., et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_a6t324bgb0sdtib3udj2mutgfa